|
|
||||||||
Research Paper |
Laboratory for Infectious Diseases Research (LIO), National Institute of Public Health and Environment, 3720 BA Bilthoven, The Netherlands1
Eijkman Winkler Institute for Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands2
Author for correspondence: Frits R. Mooi. Tel: +31 30 2743091. Fax: +31 30 2744449. e-mail: fr.mooi{at}rivm.nl
Despite the introduction of mass vaccination in 1953 in The Netherlands, pertussis is currently an endemic disease with regular epidemic outbreaks. Changes in the Bordetella pertussis population in the first 20 years after the introduction of vaccination were studied by indexing IS1002 fingerprint types, fimbrial serotypes and 15 genes encoding surface proteins. Three periods were compared, the pre-vaccination period (19491952) and two subsequent periods, 19531958 and 19651972. Except for fimbrial serotypes, no changes were observed in the B. pertussis population between the first two periods. Mortality decreased fivefold and 543-fold in the periods 19531958 and 19651972, respectively, compared to the pre-vaccination period. The largest decrease in mortality coincided with significant changes in the B. pertussis population with respect to the frequencies of fimbrial serotypes, fingerprint types and ptxS1 alleles. A new fingerprint type (ft29), associated with the novel ptxS1 allele ptxS1A was observed in 50% of the isolates in the period 19651972. Of the 15 investigated genes, only ptxS1 showed a mismatch between the vaccine strains and clinical isolates, suggesting that it may have played a role in driving the observed changes. It is proposed that, within 1020 years after the introduction of mass vaccination, an adaptive response occurred consisting of clonal expansion of strains, which expressed a pertussis toxin variant distinct from the vaccine variants. This adaptation had very little, if any, effect on mortality, however.
Keywords: population structure, serotyping, gene polymorphism, fingerprint typing
This article has been cited by other articles:
![]() |
D. J. Litt, S. E. Neal, and N. K. Fry Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type J. Clin. Microbiol., March 1, 2009; 47(3): 680 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bottero, M. E. Gaillard, M. Fingermann, G. Weltman, J. Fernandez, F. Sisti, A. Graieb, R. Roberts, O. Rico, G. Rios, et al. Pulsed-Field Gel Electrophoresis, Pertactin, Pertussis Toxin S1 Subunit Polymorphisms, and Surfaceome Analysis of Vaccine and Clinical Bordetella pertussis Strains Clin. Vaccine Immunol., November 1, 2007; 14(11): 1490 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gagneux, K. DeRiemer, T. Van, M. Kato-Maeda, B. C. de Jong, S. Narayanan, M. Nicol, S. Niemann, K. Kremer, M. C. Gutierrez, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis PNAS, February 21, 2006; 103(8): 2869 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Boven, F. R Mooi, J. F.P Schellekens, H. E de Melker, and M. Kretzschmar Pathogen adaptation under imperfect vaccination: implications for pertussis Proc R Soc B, August 7, 2005; 272(1572): 1617 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elomaa, A. Advani, D. Donnelly, M. Antila, J. Mertsola, H. Hallander, and Q. He Strain Variation among Bordetella pertussis Isolates in Finland, Where the Whole-Cell Pertussis Vaccine Has Been Used for 50 Years J. Clin. Microbiol., August 1, 2005; 43(8): 3681 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Preston Bordetella pertussis: the intersection of genomics and pathobiology Can. Med. Assoc. J., July 5, 2005; 173(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. M. van Amersfoorth, L. M. Schouls, H. G. J. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. W. von Konig, M. Riffelmann, C. Vahrenholz, N. Guiso, et al. Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies J. Clin. Microbiol., June 1, 2005; 43(6): 2837 - 2843. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. Hallander, A. Advani, D. Donnelly, L. Gustafsson, and R.-M. Carlsson Shifts of Bordetella pertussis Variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs J. Clin. Microbiol., June 1, 2005; 43(6): 2856 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kodama, K. Kamachi, Y. Horiuchi, T. Konda, and Y. Arakawa Antigenic Divergence Suggested by Correlation between Antigenic Variation and Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates in Japan J. Clin. Microbiol., December 1, 2004; 42(12): 5453 - 5457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Register, R. E. Sacco, and G. E. Nordholm Comparison of Ribotyping and Restriction Enzyme Analysis for Inter- and Intraspecies Discrimination of Bordetella avium and Bordetella hinzii J. Clin. Microbiol., April 1, 2003; 41(4): 1512 - 1519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |